What Actually Happens in Month 2 of Mounjaro

You're probably facing your first dose increase right now

If you started Mounjaro at 2.5mg (which is where treatment begins, because that dose gives the body time to settle rather than immediately treating at full strength) month two is likely when your prescriber moves you to 5mg. Some people stay at 2.5mg a little longer if they're still experiencing noticeable side effects; others move up earlier if they're tolerating it well. The prescriber makes that call based on your response, not a calendar.

The 5mg step is where most people first notice a meaningful shift in appetite. Meals feel smaller. The urge to snack between them often fades. Some people describe food as genuinely less interesting, which can be a surprise. If you've been curious about the mechanism behind that, the tirzepatide overview explains how Mounjaro's dual action on GIP and GLP-1 receptors affects hunger signals differently from older injectable medicines.

Worth knowing: if you do move up to 5mg, the GI side effects that settled in your first weeks can briefly return. Nausea, loose stools and indigestion are the most common, the NHS tirzepatide page covers the full side-effect profile and when to seek help. It usually passes within a week or two of the new dose.

What month 2 weight loss tends to look like, and why the range is wide

People ask this question a lot, and the honest answer is that individual results at eight weeks span a wide range. A meaningful number of people have lost somewhere between three and six per cent of their starting weight by this point; others have lost more, some less. In the SURMOUNT-1 clinical trial, participants at the highest doses ultimately lost around 20% of body weight over 72 weeks, but the trajectory in the early months is gradual by design. The medicine is titrated slowly precisely because rushing the dose doesn't improve long-term outcomes and increases the chance of side effects that cause people to stop.

What tends to predict a stronger month-two response is the combination of the medicine working alongside real changes in eating patterns. Mounjaro slows gastric emptying and reduces appetite, but if you're eating past fullness cues or skimming on protein and vegetables, the pharmacological effect is doing more work than it needs to. Staying well hydrated matters too, especially if nausea is still lingering.

If you want to understand what the first month looked like before comparing, our guide to being one month on Mounjaro sets that context, and a closer look at what that first month on Mounjaro involves can help you see how far you've already come.

Building a routine around month 2, and an unexpected side effect worth knowing

By now, injection day probably has a rhythm. Some people tie it to the same morning each week, a Monday-morning habit before the kettle has even finished boiling. The pen lives in the fridge door, comes out ten minutes before use so it's not cold, and goes back in. That kind of structure matters more than it sounds: missing a dose doesn't just break the week's routine, it can trigger a temporary return of appetite. Your Patient Information Leaflet covers what to do if a dose is delayed.

One thing that catches people off-guard around this time is a change in bowel habits. Constipation is particularly common in month two as gastric emptying slows and food intake drops. Increased water, fibre from vegetables and legumes, and physical movement usually help, if it becomes persistent, it's worth mentioning to your prescriber. There's a separate guide on bile acid malabsorption and Mounjaro for anyone noticing the opposite: looser stools that persist beyond the adjustment period.

Women taking an oral contraceptive should note that NHS guidance recommends adding a barrier method for the first four weeks of treatment and for four weeks after each dose increase, because Mounjaro's effect on gastric emptying may reduce pill absorption. NHS England's weight-management injections guidance covers this and the HRT considerations in full.

When month 2 raises questions about whether to continue

Not everyone reaches eight weeks with a smooth experience. Some people feel the weight loss is slower than they expected; others are managing side effects that are taking the shine off early progress. Both are worth discussing with a prescriber rather than deciding alone to stop or push through at a higher dose.

NICE's appraisal of tirzepatide notes that if less than five per cent of body weight is lost after six months at the highest tolerated dose, continuing treatment should be reviewed. Month two is nowhere near that assessment point, it's too early to draw conclusions about whether the medicine is working for you. What matters at this stage is that side effects are manageable and that your prescriber has the information they need to support any adjustments.

If you started treatment elsewhere and are considering a transfer, or if you're thinking about starting Mounjaro and want to understand what the full journey looks like, the Mounjaro overview covers eligibility and the private prescription route. A detailed look at the cost of staying on treatment in the UK is available on the Mounjaro price comparison page. When you're ready to speak to a prescriber, start your free consultation, a GPhC-registered prescriber, not software, reviews your case the same day.